Blog
RSS FeedPosted by Michael Wonder on 07 May 2020
Generic drug maker admits to fixing prices for cholesterol medication
7 May 2020 - For conspiring to inflate drug prices, Apotex will pay $24 million and cooperate with the Justice Department’s ...
Posted by Michael Wonder on 06 May 2020
Jaguar Health says recent drug price hikes not tied to COVID-19 pandemic
6 May 2020 - Jaguar Health Inc’s recent price hikes on its anti-diarrhoeal drug, Mytesi, were not tied to the ...
Posted by Michael Wonder on 06 May 2020
Will Gilead price its coronavirus drug for public good or company profit?
7 May 2020 - Gilead faces a new dilemma in deciding how much it should profit from the only treatment so ...
Posted by Michael Wonder on 06 May 2020
Remdesivir helps coronavirus patients — but at what cost?
6 May 2020 - Drug maker Gilead is known for creating breakthrough drugs and selling them at a premium. ...
Posted by Michael Wonder on 05 May 2020
Teva and Celltrion Healthcare announce the launch of Truxima (rituximab-abbs) injection for rheumatoid arthritis, the only biosimilar to Rituxan (rituximab) available in the United States for this indication
4 May 2020 - Truxima is also now available for the treatment of granulomatosis with polyangiitis (Wegener’s granulomatosis) and microscopic polyangiitis. ...
Posted by Michael Wonder on 05 May 2020
Gilead's drug pricing in the crosshairs again in wake of OK to use remdesivir against COVID-19
4 May 2020 - Gilead plans to spend $1 billion on its COVID-19 drug remdesivir. Now some members of Congress ...
Posted by Michael Wonder on 04 May 2020
U.S. law makers question Jaguar Health on price hike of drug that may help treat COVID-19 patients
4 May 2020 - The chair of a House of Representatives committee and a fellow Democratic committee member on Monday ...
Posted by Michael Wonder on 25 Apr 2020
Maker of drug touted as coronavirus cure accuses China of gouging
24 April 2020 - Hydroxychloroquine controversially pushed by Trump as COVID-19 remedy. ...
Posted by Michael Wonder on 23 Apr 2020
Drug maker tripled the price of a pill as it pursued coronavirus use
23 April 2020 - This month, Jaguar Health more than tripled the price of its lone FDA approved drug, right after ...
Posted by Michael Wonder on 15 Apr 2020
Merck announces US launch of Ontruzant (trastuzumab-dttb), a biosimilar of Herceptin (trastuzumab)
15 April 2020 - Merck today announced the U.S. launch of Ontruzant (trastuzumab-dttb), as a biosimilar of the reference biologic ...
Posted by Michael Wonder on 14 Apr 2020
Potential coronavirus drugs may cost as little as $1, study says
10 April 2020 - Treatments being studied sell for hundreds of times their cost. ...
Posted by Michael Wonder on 08 Apr 2020
Pharmaceutical profits and public health are not incompatible
8 April 2020 - We need the capital and creativity of the private sector to take on the coronavirus. ...
Posted by Michael Wonder on 23 Mar 2020
Intra-Cellular prices schizophrenia drug at $1,320 per month
23 March 2020 - Intra-Cellular Therapies said on Monday its lead drug to treat schizophrenia was now available at U.S. ...
Posted by Michael Wonder on 21 Mar 2020
U.S. pharma that makes potential coronavirus drug touted by Donald Trump doubled price to $19.88 a pill
20 March 2020 - Company calls hike in January during China outbreak coincidental and said it restored old price. ...
Posted by Michael Wonder on 04 Mar 2020
Drug shortages in the United States. Are some prices too low?
3 March 2020 - The US public identified lowering prescription drug prices as the top health priority for Congress in 2019. ...